Momentum will be offering a webinar entitled "Key Developments in Biosimilar Litigation, Part II" on June 23, 2015 from 1:00 to 1:45 pm (Eastern). Louis E. Fogel, Paul D. Margolis, Steven R. Trybus of Jenner & Block will explore new Federal Circuit arguments being made and considered in interpreting the Amgen v. Sandoz cases relating to the BPCIA, and discuss whether the patent dance is mandatory and when the Notice of Commercial Sale is appropriate.
There is no fee for the webinar. Those interested in registering for the webinar, can do so here.
Comments